The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Baxfendy
baxdrostat · BAXDROSTAT 2 mg/1 · Tablet, Film Coated · Oral · AstraZeneca Pharmaceuticals LP
NDC 00310-6002-30 · 30 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA219878
- TE code
- —
- Approval date
- May 15, 2026
- Patents / exclusivity
- 2 patents, 2 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NCE | May 15, 2031 |
| exclusivity | NCE | May 15, 2031 |
| patent | 9353081 | Feb 4, 2033 |
| patent | 9353081 | Feb 4, 2033 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of baxdrostat (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AstraZeneca AB | BAXDROSTAT 1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AstraZeneca AB | BAXDROSTAT 2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AstraZeneca Pharmaceuticals LP | BAXDROSTAT 1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AstraZeneca Pharmaceuticals LP | BAXDROSTAT 2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Baxfendy — NDC 00310-6002-30," retrieved September 3, 2026, https://drugdashboards.com/drug/00310600230.
Free to cite with attribution — see how the data is put together.